Magenta Therapeutics competitorsClear all
Magenta Therapeutics's top competitors include PacifiCord, EpiVax, Transgene and DBV Technologies.
| Save Comparison |  Magenta Therapeutics Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases. |  EpiVax EpiVax has developed comprehensive analytical capabilities in the field of computational immunology. |  Transgene Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. |  DBV Technologies We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments. | |
Founding Date | Founding Date 2016 | Founding Date 2008 | Founding Date 1998 | Founding Date N/A | Founding Date 2002 |
Type | Type Public | Type Subsidiary | Type Private | Type Public | Type Public |
Tags | Tags Healthcare | ||||
Locations | Locations Cambridge, US HQ | Locations Irvine, US HQ | Locations Providence, US HQ | Locations Illkirch, FR HQ Shanghai, CN Lyon, FR Boston, US | Locations Montrouge, FR HQ Bagneux, FR New York, US Summit, US |
Employees | Employees 72 | Employees 7 | Employees 32 | Employees 136 | Employees 311 |
Twitter followers | Twitter followers 2 k | Twitter followers 548 | Twitter followers 379 | Twitter followers 1.4 k | Twitter followers 1.5 k |
Number of tweets (last 30 days) | Number of tweets (last 30 days) 3 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 2 | Number of tweets (last 30 days) 9 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) 7.7 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 1.5 | Average likes per tweet (last 30 days) 1.3 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) 100% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 50% | Percentage of tweets with engagement (last 30 days) 88.89% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 429432 | Alexa Website Rank 271194 | Alexa Website Rank 361738 | Alexa Website Rank 221574 | Alexa Website Rank 292854 |
Employee Rating | Employee Rating N/A | Employee Rating N/A | Employee Rating 3.9 | Employee Rating 4.4 | Employee Rating 3.4 |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €13.1m (FY, 2019) |
Net income | Net income ($76.8m) (FY, 2019) | Net income N/A | Net income N/A | Net income N/A | Net income (€153.6m) (FY, 2019) |
Funding | |||||
Total funding raised | Total funding raised $ 150.5m | Total funding raised N/A | Total funding raised $ 3.2m | Total funding raised N/A | Total funding raised $ 28.2m |
For sources of this data, please see the company profile
View company profiles
EpiVax
HQ
Providence, US
Employees
32
EpiVax has developed comprehensive analytical capabilities in the field of computational immunology.
View companyTransgene
HQ
Illkirch, FR
Employees
136
Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases.
View companyDBV Technologies
HQ
Montrouge, FR
Employees
311
We are committed to finding a safe, effective and patient-friendly therapy for food and pediatric allergy patients, for whom there are no currently approved treatments.
View company